Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Chapman

Showing results (741-750 of 1,011) with videos related to

Pageof 102
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 19, 2015
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 TrialRon T Gansevoort, Esther Meijer, Arlene B Chapman, et al.
The Pharmacogenomics Journal|February 13, 2013
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African AmericansJ L Del-Aguila, A L Beitelshees, R M Cooper-Dehoff, et al.
Anaesthesia|March 3, 2017
A randomised trial of peri-operative positive airway pressure for postoperative delirium in patients at risk for obstructive sleep apnoea after regional anaesthesia with sedation or general anaesthesia for joint arthroplastyJ W Nadler, J L Evans, E Fang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 24, 2017
Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertensionMai Mehanna, Yan Gong, Caitrin W McDonough, et al.
Molecular & Cellular Proteomics : MCP|July 30, 2014
Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individualsSylvain Lehoux, Rongjuan Mi, Rajindra P Aryal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancerP B Chapman, T J Lester, E S Casper, et al.
North American Spine Society Journal|June 23, 2025
Spinal cord stimulator utilization trends and predictors of unsuccessful trial-to-implant conversionWesley Day, Gwyneth C Maloy, Adam D Winter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancersPatricia M LoRusso, Smitha S Krishnamurthi, John J Rinehart, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 19, 2016
Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled TrialNiek F Casteleijn, Jaime D Blais, Arlene B Chapman, et al.
The New England Journal of Medicine|September 8, 2010
Inhibition of mutated, activated BRAF in metastatic melanomaKeith T Flaherty, Igor Puzanov, Kevin B Kim, et al.
Pageof 102

Showing results (741-750 of 1,011) with videos related to

Sort By:
Pageof 102
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 19, 2015
Albuminuria and tolvaptan in autosomal-dominant polycystic kidney disease: results of the TEMPO 3:4 TrialRon T Gansevoort, Esther Meijer, Arlene B Chapman, et al.
The Pharmacogenomics Journal|February 13, 2013
Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African AmericansJ L Del-Aguila, A L Beitelshees, R M Cooper-Dehoff, et al.
Anaesthesia|March 3, 2017
A randomised trial of peri-operative positive airway pressure for postoperative delirium in patients at risk for obstructive sleep apnoea after regional anaesthesia with sedation or general anaesthesia for joint arthroplastyJ W Nadler, J L Evans, E Fang, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|September 24, 2017
Blood pressure response to metoprolol and chlorthalidone in European and African Americans with hypertensionMai Mehanna, Yan Gong, Caitrin W McDonough, et al.
Molecular & Cellular Proteomics : MCP|July 30, 2014
Identification of distinct glycoforms of IgA1 in plasma from patients with immunoglobulin A (IgA) nephropathy and healthy individualsSylvain Lehoux, Rongjuan Mi, Rajindra P Aryal, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1987
Clinical pharmacology of recombinant human tumor necrosis factor in patients with advanced cancerP B Chapman, T J Lester, E S Casper, et al.
North American Spine Society Journal|June 23, 2025
Spinal cord stimulator utilization trends and predictors of unsuccessful trial-to-implant conversionWesley Day, Gwyneth C Maloy, Adam D Winter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancersPatricia M LoRusso, Smitha S Krishnamurthi, John J Rinehart, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 19, 2016
Tolvaptan and Kidney Pain in Patients With Autosomal Dominant Polycystic Kidney Disease: Secondary Analysis From a Randomized Controlled TrialNiek F Casteleijn, Jaime D Blais, Arlene B Chapman, et al.
The New England Journal of Medicine|September 8, 2010
Inhibition of mutated, activated BRAF in metastatic melanomaKeith T Flaherty, Igor Puzanov, Kevin B Kim, et al.
Pageof 102